Literature DB >> 9323057

Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study.

M Muggeo1, G Verlato, E Bonora, G Zoppini, M Corbellini, R de Marco.   

Abstract

BACKGROUND: We recently reported that long-term fasting plasma glucose (FPG) instability predicts all-cause mortality in elderly patients with non-insulin-dependent diabetes mellitus (NIDDM). The aim of the present study was to evaluate whether glucose instability, as represented by the coefficient of variation of FPG concentrations (CV-FPG) measured during a 3-year period, can predict specific causes of death in the subsequent 5 years. METHODS AND
RESULTS: Five hundred sixty-six elderly patients with NIDDM were followed up for 5 years to assess mortality and causes of death. All FPG determinations of the 3 years preceding the follow-up available in the clinical records were collected and analyzed. Patients were grouped in tertiles of mean FPG, CV-FPG, and the slope of FPG. These parameters of glucose control, as well as sex, age, duration of diabetes, insulin treatment, cigarette smoking, hypertension, and total cholesterol, were included in a multivariate analysis of mortality. During the follow-up, 63 men and 128 women died. Diabetes- and malignancy-related mortality were not independently associated with any parameter of glucose control, whereas cardiovascular-related mortality was independently associated with CV-FPG (P=.007) but not with the mean or the slope of FPG. In particular, the relative risk of cardiovascular mortality in subjects in tertile III versus tertile I of CV-FPG was 2.40 (95% CI, 1.28 to 4.53).
CONCLUSIONS: These results indicate that FPG instability is a predictor of cardiovascular-related mortality in elderly patients with NIDDM and suggest that glucose stability might be a goal in the management of these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323057     DOI: 10.1161/01.cir.96.6.1750

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  29 in total

1.  Glycated haemoglobin, diabetes, and mortality in men. Maybe disturbance in physiological mechanisms regulating blood glucose is risk factor for cardiovascular death.

Authors:  R J Jarrett
Journal:  BMJ       Date:  2001-04-21

Review 2.  Insulin degludec and insulin degludec/insulin aspart: a review of their use in the management of diabetes mellitus.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

3.  Ablation of NF-kappaB expression by small interference RNA prevents the dysfunction of human umbilical vein endothelial cells induced by high glucose.

Authors:  Gang Chen; Xiaoyan Shen; Jin Yao; Feng Chen; Xu Lin; Yufang Qiao; Tingting You; Fenghui Lin; Xiaowen Fang; Xin Zou; Lixiang Lin
Journal:  Endocrine       Date:  2008-11-08       Impact factor: 3.633

4.  Adiposity predicts cognitive decline in older persons with diabetes: a 2-year follow-up.

Authors:  Angela Marie Abbatecola; Fabrizia Lattanzio; Liana Spazzafumo; Anna Maria Molinari; Michele Cioffi; Raffaele Canonico; Luigi Dicioccio; Giuseppe Paolisso
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

5.  Is A1C Variability an Independent Predictor for the Progression of Atherosclerosis in Type 2 Diabetic Patients?

Authors:  Chul Sik Kim; So Young Park; Sung Hoon Yu; Jun Goo Kang; Ohk Hyun Ryu; Seong Jin Lee; Eun Gyung Hong; Hyeon Kyu Kim; Doo-Man Kim; Jae Myung Yoo; Sung Hee Ihm; Moon Gi Choi; Hyung Joon Yoo
Journal:  Korean Diabetes J       Date:  2010-06-30

6.  HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.

Authors:  C C Hsu; H Y Chang; M C Huang; S J Hwang; Y C Yang; Y S Lee; S J Shin; T Y Tai
Journal:  Diabetologia       Date:  2012-08-26       Impact factor: 10.122

7.  Hyperglycemia increases the risk of death in extremely preterm baboons.

Authors:  Cynthia L Blanco; Lisa L McGill-Vargas; Donald McCurnin; Amy R Quinn
Journal:  Pediatr Res       Date:  2012-12-07       Impact factor: 3.756

Review 8.  Insulin detemir: a review of its use in the management of diabetes mellitus.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

9.  Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.

Authors:  Matthew W Segar; Kershaw V Patel; Muthiah Vaduganathan; Melissa C Caughey; Javed Butler; Gregg C Fonarow; Justin L Grodin; Darren K McGuire; Ambarish Pandey
Journal:  Diabetes Care       Date:  2020-06-15       Impact factor: 19.112

10.  Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study.

Authors:  Kyoung Jin Kim; Jimi Choi; Jae Hyun Bae; Kyeong Jin Kim; Hye Jin Yoo; Ji A Seo; Nan Hee Kim; Kyung Mook Choi; Sei Hyun Baik; Sin Gon Kim; Nam Hoon Kim
Journal:  Diabetes Metab J       Date:  2020-10-20       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.